Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning

Annals of the New York Academy of Sciences

Volumn 1095, Issue , 2007, Pages 251-261

  Jancsó, Gábor ^a   Cserepes, Barbara ^a   Gasz, Balázs ^a   Benkó, László ^a   Borsiczky, Balázs ^a   Ferenc, Andrea ^a   Kürthy, Mária ^a   Rácz, Boglárka ^a   Lantos, János ^a   Gal, János ^b   Arató, Endre ^a   Sínayc, Lószló ^a   Wéber, György ^a   Róth, Erzsébet ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Heme oxygenase; Myocardium; Preconditioning

Indexed keywords

HEME OXYGENASE 1; LACTATE DEHYDROGENASE; PROTOPORPHYRIN ZINC; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; COMPETITIVE INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME RELEASE; ENZYME SYNTHESIS; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SIMULATION; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENETICS; HEART MUSCLE; PHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; HEME OXYGENASE-1; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIUM; RATS; RATS, WISTAR;

EID: 34247898930     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.029     Document Type: Conference Paper

References (31)

1. MURRY, C.E. 1986. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124-1136.
2. JENKINS, D.B. 1995. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J. Mol. Cell. Cardiol. 27: 1623-1632.
3. YELLON, D.M. 1992. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc. Res. 26: 983-987.
4. HAGAR, J.M. 1991. Effect of preconditioning ischaemia on reperfusion arrhythmias after coronary artery occlusion and reperfuson in the rat. Circ. Res. 68: 61-68.
5. VEGH, A. 2002. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs. Br. J. Pharmacol. 137: 1107-1115.
6. STEENBERGER, C. 1990. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischaemic injury in perfused rat heart. Circ. Res. 66: 135-146.
7. REIMER, K.A. 1986. Four brief periods of myocardial ischaemia cause no cummulative ATP loss or necrosis. Am. J. Physiol. 251: H1306-H1315.
8. STEIN, A.B. 2004. Delayed adaptation of the heart to stress: late preconditioning. Stroke 35(11 Suppl 1): 2676-2679.
9. CARROLL, R. 1999. Myocardial adaptation to ischaemia - the preconditioning phenomenon. Int. J. Cardiol. 68: S93-S101.
10. MARBER, M.S. 1993. Cardiac stress protein elevation 24 hours following brief ischaemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272.
11. Armstrong, S.C. 1995. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J. Mol. Cell. Cardiol. 27: 1765-1774.
12. MAINES, M.D. 1988. Heme oxygenase: function, multiplicity, regulatory mechanism, and clinical applications. FASEB J. 2: 2557-2568.
13. AKAMATSU, Y. 2004. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J. 18: 771-772.
14. MASINI, E. 2003. Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp. Biol. Med. (Maywood) 228: 546-549.
15. VULAPALLI, S.R. 2002. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am. J. Physiol. Heart Circ. Physiol. 283: H688-H694.
16. LU, R. 2002. Heme oxygenase-1 pathway is involved in delayed protection induced by heat stress against cardiac ischemia-reperfusion injury. Int. J. Cardiol. 82: 133-140.
17. ESUMI, K. 1991. NADH measurements in adult rat myocytes during simulated ischemia. Am. J. Physiol. 260: H1743-H1752.
18. ZHOU, Y. 2000. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am. J. Physiol. Heart Circ. Physiol. 279: H429-H436.
19. MARAIS, E. 2001. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion. J. Mol. Cell. Cardiol. 33: 769-778.
20. RAYNAL, P. 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63-93.
21. GLANEMANN, M. 2005. Cobalt-protoporphyrin induced heme oxygenase overexpression and its impact on liver regeneration. Transplant Proc. 37: 3223-3225.
22. YET, S.F. 2001. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 89: 168-173.
23. JANCSO, G. 2005. Effect of acetylsalicylic acid on nuclear factor-kappaB activation and on late preconditioning against infarction in the myocardium. J. Cardiovasc. Pharmacol. 46: 295-301.
24. JANCSO, G. 2004. Dynamism of NF-kappaB and AP-1 activation in the signal transduction of ischaemic myocardial preconditioning. Eur. Surg. Res. 36: 129-135.
25. YOSHIDA, T. 2001. H (mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 103: 1695-1701.
26. KATORI, M. 2002. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73: 287-292.
27. CLARK, J.E. 2000. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 278: H643-H651.
28. STOCKER, R. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046.
29. BARANANO, D.E. 2002. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA 99: 16093-16098.
30. SOARES, M.P. 2002. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid. Redox Signal 4: 321-329.
31. AMERSI, F. 2002. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35: 815-823.